Skip to main content

Table 1

From: Assessment of left ventricular systolic and diastolic function in patients with sarcoidosis with and without cardiac involvement by magnetic resonance feature tracking at 1.5T: a follow up study

 

Initial exam

       
 

PSSR

PDSR

PSECC

EDSR

Age (y)

LVEF (%)

LVEDV (ml)

IVSD (mm)

Group1 (n= 14)

-1,09 ± 0,75

1,14 ± 0,35

-18,43 ± 4,27

53,24 ± 15,26

50,57 ± 13,51

62,15 ± 8,87

120 ± 24,42

10,63 ± 1,66

Group2 (n = 9)

-1,49 ± 0,37

1,42 ± 0,42

-22,21 ± 6,47

75,1 ± 22,62

51,89 ± 5,88

68,33 ± 7,75

106,33 ± 6

10,69 ± 1,69

Group3 (n = 37)

-1,51 ± 0,39

1,36 ± 0,1

-24,33 ± 3,5

77,25 ± 5,06

50,78 ± 12,66

64,84 ± 4,76

116,53 ± 31,64

9,47 ± 1,62

Group4 (n = 20)

-1,51 ± 0,28

1,37 ± 0,48

-24,53 ± 4,38

79,74 ± 25,59

59,32 ± 28,99

61,88 ± 7,07

135,99 ± 9,19

9,7 ± 1,84

  

Significance (p-value)

      

Group1 vs. Group2

0,1813

0,1153

0,1132

0,0133

    

Group1 vs. Group3

0,0105

0,1440

0,0010

0,0006

    

Group1 vs. Group4

0,0248

0,1347

0,0002

0,0014

    
  1. FT results of group 1-4 including 2-tailed t-test results and patient characteristics.